The susceptibility of a strain of Giardia lamblia to benzimidazole carbamates, 5-nitroimidazoles, nitrofurans and other drugs was studied in vitro. Albendazole was the most active compound, with a 50% inhibitory concentration (IC50) of 0.01 mg/L and a minimal lethal concentration (MLC) of < 0.04 mg/L; the IC50 of mebendazole was 0.06 mg/L and the MLC < 0.5 mg/L. Among the 5-nitroimidazoles tested, ornidazole was the most effective (IC50 0.12 mg/L); tinidazole, metronidazole, secnidazole and hemezole were less active. Nifuroxazide, etofamide and nalidixic acid exhibited modest anti-giardial activity; quinfamide did not inhibit the growth of the parasite at a concentration of 200 mg/L. Albendazole and mebendazole are promising candidates for clinical use and should be further evaluated.
WalshJ. A. Estimating the burden of illness in the tropics. In
WarrenK. S.,
MahmoudA. A. F.
(eds) Tropical and geographic medicine New York: McGraw-Hill; 19841073–1085
KavousiS. Giardiasis in infancy and childhood: a prospective study of 160 cases with comparison of quinacrine (Ata-brine®) and metronidazole (Flagyl®). Am J Trop Med Hyg1979; 28:19–23
LeviG. C.,
ArmandoD.,
E AvilaC.,
NetoV. A. Efficacy of various drugs for treatment of giardiasis. A Comparative Study. Am J Trop Med Hyg1977; 26:564–565
DavidsonR. A. Treatment of giardiasis: the North American perspective. In
MeyerE. A.
(ed) Giardiasis Amsterdam: Elsevier Science Publishers B. V.; 1990325–334
GordtsB.,
HemelhofW.,
AsselmanC.,
ButzlerJ.-P. In-vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents. Anti-microb Agents Chemother1985; 28:378–380
GillinF. D.,
DiamondL. S. Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine and other antimicrobial agents. J Antimicrob Chemother1981; 8:305–316
MeloniB. P.,
ThompsonR. C. A.,
ReynoldsonJ. A.,
SevilleP. Albendazole: a more effective antigiardial agent in vitro than metronidazole or tinidazole. Trans R Soc Trop Med Hyg1990; 84:375–379
EdlindT. D.,
HangT. L.,
ChakrabortyP. R. Activity of the anthelmintic benzimidazoles against Giardia lamblia in vitro
. J Infect Dis1990; 162:1408–1411
GasconJ.,
MorenoA.,
VailsM. E.,
MiroJ. M.,
CorachanM. Failure of mebendazole treatment in Giardia lamblia infection. Trans R Soc Trop Med Hyg1989; 83:647
SlighterR. G.,
YarinskyA.,
DrobeckH. P.,
BaileyD. M. Activity of quinfamide against natural infections of Entamoeba criteci in hamsters: a new potent agent for intestinal amoebiasis. Parasitology1980; 81:157–168
LaceyE. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int J Parasitol1988; 18:885–936
BorehamP. F.,
PhillipsR. E.,
ShepherdR. W. A comparison of the in-vitro activity of some 5-nitroimidazoles and other compounds against Giardia intestinalis
. J Antimicrob Chemother1985; 16:589–595